Holdings of JNL/T. Rowe Price Mid-Cap Growth Fund
JNL Series Trust · 114 declared positions · as of Mar 31, 2026
Original filing · Net assets 4B $ · Ten largest lines: 20.4 % of the equity sleeve
Sector breakdown
- Consumer discretionary 14.0 %
- Technology 13.1 %
- Health care 10.7 %
- Industrials 10.4 %
- Financials 4.2 %
- Energy 3.9 %
- Materials 2.7 %
- Consumer staples 0.8 %
- Communication 0.3 %
- Unattributed 39.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 92.2 %
- BM 2.0 %
- GB 1.8 %
- DK 0.8 %
- CA 0.8 %
- JE 0.7 %
- CH 0.7 %
- NL 0.6 %
- DE 0.4 %
- KY 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 104 | 3.6B $ | 92.19 % |
| 2 | BM | 1 | 77.3M $ | 1.98 % |
| 3 | GB | 1 | 69.3M $ | 1.78 % |
| 4 | DK | 1 | 31.7M $ | 0.81 % |
| 5 | CA | 1 | 29.9M $ | 0.77 % |
| 6 | JE | 1 | 27.3M $ | 0.70 % |
| 7 | CH | 2 | 26.6M $ | 0.68 % |
| 8 | NL | 1 | 23.1M $ | 0.59 % |
| 9 | DE | 1 | 15.4M $ | 0.39 % |
| 10 | KY | 1 | 4M $ | 0.10 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Ralliant Corp | 224,031 | 9.3M $ | 0.23 % |
| 102 | CRISPR Therapeutics AG | 189,561 | 9M $ | 0.22 % |
| 103 | CG oncology Inc | 132,293 | 9M $ | 0.22 % |
| 104 | Unity Software Inc | 388,478 | 8.5M $ | 0.21 % |
| 105 | Caris Life Sciences Inc | 476,374 | 8.5M $ | 0.21 % |
| 106 | DraftKings Inc | 388,900 | 8.4M $ | 0.21 % |
| 107 | Kymera Therapeutics Inc | 93,100 | 7.8M $ | 0.19 % |
| 108 | Amphenol Corp | 60,800 | 7.7M $ | 0.19 % |
| 109 | McGraw Hill Inc | 550,129 | 7.5M $ | 0.19 % |
| 110 | Aurora Innovation Inc | 1,733,211 | 7.1M $ | 0.18 % |
| 111 | Revolution Medicines Inc | 63,800 | 6.2M $ | 0.15 % |
| 112 | QuidelOrtho Corp | 334,400 | 5.5M $ | 0.14 % |
| 113 | Nuvalent Inc | 40,619 | 4.2M $ | 0.10 % |
| 114 | Bullish | 112,632 | 4M $ | 0.10 % |